With little fanfare, the Biden administration stacked a critical committee that helps set U.S. vaccination policy with new ...
President Trump said he would take health agencies in a new direction on the campaign trail and has chosen some controversial ...
Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...
The US Food and Drug Administration (FDA) convenes public advisory committee meetings to address issues in new drug applications (NDAs), biologics license applications (BLAs), or clinical trials ...
Going forward, we may see more instances in which insurers deny or (temporarily) severely restrict coverage of accelerated ...
The head of the FDA’s artificial-intelligence-focused Digital Center of Excellence, Troy Tazbaz, is departing the agency ...
The FDA approved 16 psychiatric drugs over the last decade, most of which shared similar mechanisms of action with previously ...
The Health and Human Services Office of Inspector General has found that, in a few cases, FDA officials veered from the accelerated approval pathway.
Members of two of the Environmental Protection Agency's most influential advisory committees, tasked with providing ...